Video

Blake A. Morrison Discusses the Excitement in Myeloma Research

Blake A. Morrison discusses the recent excitement in myeloma research.

Blake A. Morrison, vice president, Medical and Scientific Affairs, Multiple Myeloma Research Foundation, discusses the recent excitement in myeloma research.

Morrison touches on the approvals of Empliciti (elotuzumab), Ninlaro (ixazomib) and Darzalex (daratumumab), as well as the research into CAR T cell immunotherapy.

Read more of our coverage from the 2015 ASH Annual Meeting

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Image of man with text.
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.
Image of man with text.
Image of women, with text.
Image of Dr. with text.
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.